ResMed Inc. ( RMD.AX) - Stock Earnings
RMD.AX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 577.4 million AUD | 2.0 billion AUD |
| 2025Q3 | 527.2 million AUD | 2.0 billion AUD |
| 2025Q4 | 597.5 million AUD | 2.2 billion AUD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
RMD.AX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.4 billion AUD | 6.4 billion AUD |
| 2024 | 1.5 billion AUD | 7.0 billion AUD |
| 2025 | 2.1 billion AUD | 7.8 billion AUD |
| 2026 Est. | — | — |
RMD.AX
Price: A$27.64
Dividend Yield: 7.41%
Payout Ratio: 47.59%
Earnings Per Share: 1.41 AUD
P/E Ratio: 21.80
Exchange: ASX
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Market Capitalization: 44.8 billion
Average Dividend Frequency: 6
Years Paying Dividends: 15
DGR3: 26.13%
DGR5: 18.76%
DGR10: 12.32%